Robeco Institutional Asset Management B.V.
Source: SEC Form 13F · as of Mar 2026Robeco Institutional Asset Management B.V. holds 15 biotech & pharma companies tracked by BioSniper, totaling $1.37B in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$1.37B
BioSniper AIPage evidence connected
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 3,354,394 | $467.5M |
| REGNREGENERON PHARMACEUTICALS, INC. | 348,787 | $269.5M |
| RDYDR REDDYS LABORATORIES LTD | 17,177,882 | $237.9M |
| INCYIncyte Corp. | 2,514,383 | $236.7M |
| EXELEXELIXIS, INC. | 1,289,101 | $55.3M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 126,463 | $41.8M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 545,135 | $30.8M |
| JAZZJazz Pharmaceuticals plc | 123,082 | $23.3M |
| INSMINSMED Inc | 20,774 | $3.4M |
| HRMYHarmony Biosciences Holdings, Inc. | 104,311 | $2.9M |
| TEVATeva Pharmaceutical Industries Limited | 26,398 | $795K |
| PTCTPTC THERAPEUTICS, INC. | 6,252 | $426K |
| IONSIONIS PHARMACEUTICALS INC | 5,660 | $425K |
| IMTXImmatics N.V. | 24,034 | $236K |
| ADPTAdaptive Biotechnologies Corp | 11,652 | $162K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.